Vimarsana.com

Latest Breaking News On - Mesa laboratories inc - Page 1 : comparemela.com

Mesa Laboratories (NASDAQ:MLAB) Shares Down 5%

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s share price fell 5% on Monday . The stock traded as low as $99.51 and last traded at $99.51. 16,576 shares were traded during trading, a decline of 63% from the average session volume of 44,738 shares. The stock had previously closed at $104.80. Wall Street Analyst […]

Louisiana
United-states
America
Asia-pacific
Entrypoint-capital
Calibration-solutions
Quadrant-capital-group
Nasdaq
Mesa-laboratories-inc
Jump-financial
Biopharmaceutical-development
Pricet-rowe-associates-inc

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Purchased by Ranger Investment Management L.P.

Ranger Investment Management L.P. boosted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,682 shares of the medical instruments supplier’s stock after buying an additional 2,689 shares […]

United-states
America
Asia-pacific
Nasdaq
King-luther-capital-management-corp
Mesa-laboratories-inc
Mesa-laboratories-company-profile
Quadrant-capital-group
Biopharmaceutical-development
Exchange-commission
Calibration-solutions
Comerica-bank

Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 5.5%

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price fell 5.5% during trading on Thursday . The company traded as low as $110.47 and last traded at $110.47. 17,348 shares changed hands during trading, a decline of 60% from the average session volume of 43,789 shares. The stock had previously closed at $116.84. Analyst […]

United-states
America
Asia-pacific
Calibration-solutions
Conestoga-capital-advisors
Mesa-laboratories-company-profile
Boone-capital-management
Mesa-laboratories-inc
Glenmede-trust-co
Biopharmaceutical-development
Comerica-bank
Motley-fool-asset-management

Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results

LAKEWOOD, Colo., May 31, 2024 Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 today as previously.

Mesa-laboratories-inc
Biopharmaceutical-development
Clinical-genomics
Mesa-laboratories

Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session - AC Immune (NASDAQ:ACIU), Adaptimmune Therapeutics (NASDAQ:ADAP)

Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session - AC Immune (NASDAQ:ACIU), Adaptimmune Therapeutics (NASDAQ:ADAP)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Onemednet-corporation
Fitell-corporation
Ttec-inc
Thomas-shrader
Calidi-biotherapeutics-inc
Michelle-choehas
Donald-trump
Master-services-agreement
Sentinelone-inc
Hp-inc
Brand-engagement-network-inc
Novo-integrated-sciences-inc

vimarsana © 2020. All Rights Reserved.